One blood broker wanted $1,000 for a milliliter of blood from a recovered Covid-19 patient. Here’s why convalescent plasma is a hot commodity.
The blood business is booming.
This normally obscure trade has been set alight by the race to develop Covid-19 antibody tests, which use blood to tell whether someone has already been infected with the coronavirus. The tests are seen as key to easing lockdowns that have shut down economies around the world.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Coronavirus updates: Blood clots clogged lungs of African American COVID-19 victims, study saysCORONAVIRUS LATEST: • Autopsies on 10 African American patients who died from COVID-19 show their lungs were filled with blood clots, according to new study. • Pandemic has killed more than 355,000 people worldwide.
続きを読む »
Blood clots clogged lungs of African American COVID-19 victims, study saysRestrictions will be tightened in Seoul and surrounding areas through June 14 to stem the spread of COVID-19 after the Korean Centers for Disease Control reported 79 newly diagnosed cases—the highest increase since early April.
続きを読む »
Blood of critically ill COVID-19 patients found to be thicker than normal in small studyResearchers at Emory University studied 15 seriously ill COVID-19 patients.
続きを読む »
Covid-19 Antibody Tests Leave Some Americans With More Questions Than AnswersSome people think positive antibody-test results and medical histories show that the novel coronavirus may have been circulating months before Jan. 21, which is the date of the first-known U.S. infection
続きを読む »
Another Ford plant temporarily shuts down after an employee tests positive for Covid-19Ford temporarily suspended work at part of its Kansas City assembly plant Tuesday after another employee tested positive for Covid-19
続きを読む »
COVID-19 Antibody Tests Can Be Wrong Half The Time, CDC SaysThese blood tests have significant margins of error and should not be used to make public health recommendations, the CDC said.
続きを読む »